AGP Picks
View all

Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on July 21, 2026

Love Without Boundaries’ China Unity Initiative Surpasses 1,250 Life-Changing Surgeries
DRUID Platform Expands to Provide Greater Flexibility for Fitness-for-Duty Assessment
Junshi Biosciences Announces Acceptance of the Supplemental Application for Toripalimab plus Chemotherapy as Perioperative Treatment for Resectable Stage Ⅱ-Ⅲ NSCLC
New study finds GLP-1 receptor agonists associated with lower risk of alcohol-related hospitalization among adults with alcohol use disorder
Coalition to Improve Access to Cancer Care Applauds Reintroduction of the Cancer Drug Parity Act
CRO Marketplace LLC Launches Digital Platform to Transform How Life Science Professionals Connect with Service Providers
 Synkriom Awarded Texas DIR Contract to Deliver Technology Services for Texas Parks and Wildlife Department
U.S. House Unanimously Passes DeOndra Dixon INCLUDE Project Act – A Historic Victory for Down Syndrome Research
Jushi Holdings Inc. to Report Second Quarter 2026 Financial Results on July 28, 2026
Expecting.Ai Launches the Largest Chinese-Language Surrogate Database for Intended Parents Seeking U.S. Surrogacy
TLX591-Tx ProstACT SELECT Study Published in Cancers Journal
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
Acrivon to Highlight the Power of its AP3 Platform for Streamlined, Pathway-Based Drug Discovery and Development with Oral and Poster Presentations at AACR D3 Conference
OraSure Receives Emergency Use Authorization for Second Generation Ebola Test
Flyte Partners with Blade to Expand Vision Jet Distribution
Dentsply Sirona to Host Second Quarter Conference Call on August 6th
Mobia Medical to Report Second Quarter 2026 Financial Results on August 11, 2026
OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 4, 2026
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Publication in Cancer Research Details Atebimetinib’s Broad, Durable Preclinical Activity and Favorable Tolerability Across RAS- and RAF-Mutant Tumors via Deep Cyclic Inhibition

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Asia Healthcare Industry Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.